Navigation Links
Magellan's Dynex® Agility™ ELISA Processor Dramatically Reduces Laboratory Time and Labor in Diagnostic Testing While Ensuring the Most-Accurate Results
Date:7/27/2011

ATLANTA and CHELMSFORD, Mass., July 27, 2011 /PRNewswire/ -- Magellan Biosciences, a global manufacturer of products designed to make diagnostic testing easier, more cost-effective, and less labor intensive, unveiled its Dynex Agility microplate sample processor in Atlanta yesterday at the AACC Clinical Lab Expo. The Agility system represents a long-awaited advance for laboratories seeking to improve the workflow efficiency, cost-effectiveness, and reliability of results of open enzyme-linked immunosorbent assay (ELISA) testing systems. The Agility system significantly reduces hands-on time for ELISA test procedures, offering walk-away performance for sample and reagent loading, liquid transfer steps, plate transfers, and pipetting. ELISA immunoassays are ubiquitous in diagnostic labs, used for a wide variety of applications from infectious disease to drugs-of-abuse testing.

(Logo: http://photos.prnewswire.com/prnh/20110411/NE81210LOGO)

Breakthrough Automation for Open ELISA Systems

"The Agility system will revolutionize ELISA microplate processing," said Adrian Bunce, Magellan's executive vice president and chief innovation officer. "Open systems are usually lower volume and slower than closed ELISA instruments. The Agility system bridges the gap: never before has one instrument combined the workflow performance typical of closed ELISA systems with the flexibility of an open system. You can run more tests in less time with fewer tedious steps and costly errors."

Bunce explained that even with automated closed systems, processing errors could occur in the dozen or more required manual steps. For example, users must decant and measure reagents and monitor and stock consumables, such as pipette tips and wash buffers. The Agility system automates all these steps. "With laboratories facing ever-increasing pressure to do more with less, labor-intensive front-end procedures have become especially burdensome due to the shortage of qualified laboratory technologists and escalating demand for medical testing generated by an aging population," he added.

SmartKit™ Reagent Packs Save Time, Increase Throughput

The key to the Agility system's streamlined workflow is the SmartKit pre-packaged, direct-load reagent kit. Magellan designed the SmartKit to contain all consumables required to perform ELISA tests, and will collaborate with reagent manufacturers to develop and validate SmartKits for their ELISA assays. Generic kits for end users will also be available. Two-dimensional bar codes provide accurate and secure information to eliminate manual data input, and illuminated, color-coded access positions on the instrument guide loading for reagent pack tips, microplates, and other consumables. The Agility system has three robotic arms for sample pipetting, reagent pipetting, and transferring plates, consumables, and SmartKits. Up to 16 SmartKits can be stored on one Agility instrument at a time.  

"The SmartKit automates workflow by drastically reducing front-end set up, which eliminates half of the manual steps required with most open ELISA systems," said Bunce. "Laboratories can expect to reduce the time interacting with the system significantly and free up technician time for other tasks."

Benefits for Reagent Manufacturers

ELISA test kit manufacturers seeking to differentiate their offerings can rely on the Agility system to help their customers achieve higher levels of automation. "Marketing your ELISA reagents within the Agility system provides a significant competitive edge for securing new contracts with both existing customers and new accounts," commented Bunce. "The Agility system enables ELISA reagent companies to offer a new level of reagent–instrument integration and automation."

Agility's intuitive design requires minimal operator training and significantly lowers potential for errors. Navigation on the touch screen is simple and allows comprehensive monitoring of consumables. Attractive graphics give a full overview of all system operations – from the number of tests scheduled to remaining consumable levels.

The Agility system will be offered for limited release to reagent manufacturers this year, with full availability to end users by Q2 2012.

About Magellan (www.magellanbio.com)

Founded in 2004, Magellan's innovative technologies make diagnostic testing easier, more cost-effective, and less labor intensive. The company's products deliver the timely information that clinicians need to make appropriate treatment decisions and improve outcomes for patients. They include LeadCare-brand rapid point-of-care systems to screen children and adults for lead poisoning and Dynex®-brand automated ELISA processing systems for a wide variety of immunoassays – from infectious disease to autoimmune and food-safety testing.


'/>"/>
SOURCE Magellan Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010
2. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
3. Reportlinker Adds US Enzyme-Linked Immunosorbent Assay (ELISA) Industry
4. New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%
5. Tevas Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinsons Disease
6. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
7. New Study Finds Patient Adherence to Statin Medications Reduces Hospitalizations and Healthcare Costs
8. Senate Receives Rx Blueprint Plan That Reduces Spending and Increases Quality
9. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
10. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
11. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... NEW YORK , May 25, 2016  According ... devices reached $381 billion in 2015.  Though these ... still plenty of opportunity for success for companies ... end, in search of new growth prospects medical ... revenue on research and development (R&D) than do ...
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today announced ... for wounds and infections. This test ensures discovery ... select viruses. The test requires only a simple swab ... David G. Bostwick , MD, Chief ... facilitate wound healing: "We are excited to make ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... ... After a year and a half of planning the Multiple Pathways of Recovery Conference ... of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel ... to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... , ... Two director-level employees of Horizon Blue Cross Blue Shield of New ... honorees. The award recognizes businesswomen who excel in their fields and who have ... MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa Ponton, ...
(Date:5/27/2016)... , ... May 27, 2016 , ... This campaign aims ... stroke, which we as a society can control and change. , As nearly 795,000 ... every 40 seconds within the United States. Plus, with an estimated 129,000 of these ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... care world, this installment is bolstered by inspiring human interest stories, courtesy of ... the developing trends and tech within the industry, from leading advocates and associations—namely ...
(Date:5/26/2016)... ... , ... Despite last week’s media reports hinting at a June rate hike ... March 2017 for an interest rate increase, according to Rajeev Dhawan of the Economic ... Federal Open Market Committee (FOMC) dot charts are of interest to the press for ...
Breaking Medicine News(10 mins):